Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.

@article{Ghazi2016PhysicalCO,
  title={Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.},
  author={Islam M. Ghazi and Yukihiro Hamada and David P. Nicolau},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2016},
  volume={73 21},
  pages={
          1769-1776
        }
}
  • I. GhaziY. HamadaD. Nicolau
  • Published 1 November 2016
  • Medicine, Chemistry
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
PURPOSE The physical compatibility of commonly used agents that could be coadministered in the clinical setting with tedizolid phosphate during Y-site administration was evaluated. METHODS Tedizolid phosphate vials were reconstituted to a final concentration of 0.8 mg/mL. All other drugs were prepared according to manufacturers' recommendations and diluted with 0.9% sodium chloride injection (where applicable) to the highest standard concentrations used clinically. Y-site conditions were… 

Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration.

Enrofloxacin was physically incompatible with all tested solutions and metoclopramide or ampicillin-sulbactam could not be assessed because those admixtures also contained saline solution.

Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach

The compatibility profile described will facilitate incorporation into hospital protocols, contribute to therapy optimization and guide clinicians to avoid successive administration, consequently resulting in reduction of total infusion time, optimization of PK/PD, economizing nursing time and cost containment.

Utility of a Compatibility Chart for Continuous Infusions in the Intensive Care Unit.

The high rate of compliance with the compatibility chart suggested it was useful in preventing drug incompatibility, and this retrospective study evaluated the utility of this chart by analyzing prescriptions and incidents of incompatibilities in an ICU.

References

SHOWING 1-8 OF 8 REFERENCES

Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.

Pemetrexed disodium was incompatible with 24 drugs during simulated Y-site administration and should not be administered with them.

Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.

  • S. HousmanP. TessierD. NicolauJ. Kuti
  • Medicine, Biology
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2011
Telavancin was found to be physically compatible for 120 minutes at room temperature with 39 of the 52 drugs tested during simulated Y-site administration and Colistimethate sodium, cyclosporine, heparin sodium, imipenem-cilastatin sodium, methylprednisolone sodium succinate, and propofol were incompatible with telvancin in specific diluents.

Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.

Drug combinations for which no visual or turbidimetric incompatibility is apparent may not be chemically stable; therefore, practitioners should be cautious in applying these findings to the clinical setting.

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections

In vitro, animal, and clinical studies have failed to demonstrate that tedizolid inhibits monoamine oxidase to a clinically relevant extent, so economic analyses are needed to describe the cost-effectiveness of this agent compared with other options used for ABSSSI, particularly treatment options active against MRSA.

Drug incompatibility chemistry.

  • D. W. Newton
  • Chemistry, Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2009
Incompatibility of drug and nutrient injections is clinically hazardous, particularly when oppositely charged drug salts are mixed in relatively strong concentrations and when pH values of dilutions create more than 1% of nonionized drug forms.

Calcium and phosphate compatibility: revisited again.

  • D. W. NewtonD. Driscoll
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2008
The subject of the compatibility between calcium and phosphates was revisited in an April 1994 FDA safety alert,[1][1],[2][2] 6–16 years after the four seminal research articles appeared in